Moderate Hypofractionated Post-Prostatectomy Radiotherapy (MYSTERY) Versus Conventionally Fractionated Post-Prostatectomy Radiotherapy (COPORT) for the Patients With Localized Prostate Cancer: The Protocol of a Prospective, Randomized Trial
Introduction A few studies have examined whether the safety and efficacy of moderate hypofractionated post-prostatectomy radiotherapy (moderate HYPORT, also called MYSTERY) are equal to those of conventionally fractionated post-prostatectomy radiotherapy (COPORT) in patients with localized prostate...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-01-01
|
| Series: | Cancer Control |
| Online Access: | https://doi.org/10.1177/10732748251317682 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823857003732140032 |
|---|---|
| author | Yiyin Liang MD Weiwei Zhang MD Xianzhi Zhao MD Huojun Zhang MD, PhD |
| author_facet | Yiyin Liang MD Weiwei Zhang MD Xianzhi Zhao MD Huojun Zhang MD, PhD |
| author_sort | Yiyin Liang MD |
| collection | DOAJ |
| description | Introduction A few studies have examined whether the safety and efficacy of moderate hypofractionated post-prostatectomy radiotherapy (moderate HYPORT, also called MYSTERY) are equal to those of conventionally fractionated post-prostatectomy radiotherapy (COPORT) in patients with localized prostate cancer. Therefore, this study aims to compare the safety and efficacy of MYSTERY and COPORT in patients with postoperative prostate cancer. Methods and analysis This study is a prospective, single-center, open-label, randomized controlled clinical trial. Patients with localized prostate cancer will be randomly allocated to receive COPORT (66-74 Gy at 2 Gy per fraction) or MYSTERY (57.5-65 Gy at 2.5 Gy per fraction). The primary outcomes are radiotherapy-related gastrointestinal and genitourinary adverse events. Secondary outcomes include progression-free survival, quality of life, medical expenses, and overall survival. |
| format | Article |
| id | doaj-art-a8610f5dddcd4cb985d113aad3bf1cd5 |
| institution | Kabale University |
| issn | 1526-2359 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Cancer Control |
| spelling | doaj-art-a8610f5dddcd4cb985d113aad3bf1cd52025-02-12T04:03:19ZengSAGE PublishingCancer Control1526-23592025-01-013210.1177/10732748251317682Moderate Hypofractionated Post-Prostatectomy Radiotherapy (MYSTERY) Versus Conventionally Fractionated Post-Prostatectomy Radiotherapy (COPORT) for the Patients With Localized Prostate Cancer: The Protocol of a Prospective, Randomized TrialYiyin Liang MDWeiwei Zhang MDXianzhi Zhao MDHuojun Zhang MD, PhDIntroduction A few studies have examined whether the safety and efficacy of moderate hypofractionated post-prostatectomy radiotherapy (moderate HYPORT, also called MYSTERY) are equal to those of conventionally fractionated post-prostatectomy radiotherapy (COPORT) in patients with localized prostate cancer. Therefore, this study aims to compare the safety and efficacy of MYSTERY and COPORT in patients with postoperative prostate cancer. Methods and analysis This study is a prospective, single-center, open-label, randomized controlled clinical trial. Patients with localized prostate cancer will be randomly allocated to receive COPORT (66-74 Gy at 2 Gy per fraction) or MYSTERY (57.5-65 Gy at 2.5 Gy per fraction). The primary outcomes are radiotherapy-related gastrointestinal and genitourinary adverse events. Secondary outcomes include progression-free survival, quality of life, medical expenses, and overall survival.https://doi.org/10.1177/10732748251317682 |
| spellingShingle | Yiyin Liang MD Weiwei Zhang MD Xianzhi Zhao MD Huojun Zhang MD, PhD Moderate Hypofractionated Post-Prostatectomy Radiotherapy (MYSTERY) Versus Conventionally Fractionated Post-Prostatectomy Radiotherapy (COPORT) for the Patients With Localized Prostate Cancer: The Protocol of a Prospective, Randomized Trial Cancer Control |
| title | Moderate Hypofractionated Post-Prostatectomy Radiotherapy (MYSTERY) Versus Conventionally Fractionated Post-Prostatectomy Radiotherapy (COPORT) for the Patients With Localized Prostate Cancer: The Protocol of a Prospective, Randomized Trial |
| title_full | Moderate Hypofractionated Post-Prostatectomy Radiotherapy (MYSTERY) Versus Conventionally Fractionated Post-Prostatectomy Radiotherapy (COPORT) for the Patients With Localized Prostate Cancer: The Protocol of a Prospective, Randomized Trial |
| title_fullStr | Moderate Hypofractionated Post-Prostatectomy Radiotherapy (MYSTERY) Versus Conventionally Fractionated Post-Prostatectomy Radiotherapy (COPORT) for the Patients With Localized Prostate Cancer: The Protocol of a Prospective, Randomized Trial |
| title_full_unstemmed | Moderate Hypofractionated Post-Prostatectomy Radiotherapy (MYSTERY) Versus Conventionally Fractionated Post-Prostatectomy Radiotherapy (COPORT) for the Patients With Localized Prostate Cancer: The Protocol of a Prospective, Randomized Trial |
| title_short | Moderate Hypofractionated Post-Prostatectomy Radiotherapy (MYSTERY) Versus Conventionally Fractionated Post-Prostatectomy Radiotherapy (COPORT) for the Patients With Localized Prostate Cancer: The Protocol of a Prospective, Randomized Trial |
| title_sort | moderate hypofractionated post prostatectomy radiotherapy mystery versus conventionally fractionated post prostatectomy radiotherapy coport for the patients with localized prostate cancer the protocol of a prospective randomized trial |
| url | https://doi.org/10.1177/10732748251317682 |
| work_keys_str_mv | AT yiyinliangmd moderatehypofractionatedpostprostatectomyradiotherapymysteryversusconventionallyfractionatedpostprostatectomyradiotherapycoportforthepatientswithlocalizedprostatecancertheprotocolofaprospectiverandomizedtrial AT weiweizhangmd moderatehypofractionatedpostprostatectomyradiotherapymysteryversusconventionallyfractionatedpostprostatectomyradiotherapycoportforthepatientswithlocalizedprostatecancertheprotocolofaprospectiverandomizedtrial AT xianzhizhaomd moderatehypofractionatedpostprostatectomyradiotherapymysteryversusconventionallyfractionatedpostprostatectomyradiotherapycoportforthepatientswithlocalizedprostatecancertheprotocolofaprospectiverandomizedtrial AT huojunzhangmdphd moderatehypofractionatedpostprostatectomyradiotherapymysteryversusconventionallyfractionatedpostprostatectomyradiotherapycoportforthepatientswithlocalizedprostatecancertheprotocolofaprospectiverandomizedtrial |